MushroomBans Alert: Trump Executive Order Accelerates Psychedelic Research and Access

President Trump signed an executive order on April 18th, 2026, directing federal agencies to expedite psychedelic research and patient access. This order includes measures such as ARPA-H match-funding for state research, FDA priority vouchers for psychedelic candidates, and earlier DEA scheduling reviews. Merchants should note the expansion of 'Right to Try' pathways to include investigational Schedule I psychedelics, signaling a federal push to streamline development and potentially alter the regulatory environment.